BIOSTATISTICS SHARED RESOURCE (BSR) The Biostatistics Shared Resource (BSR) provides collaborative statistical support to Consortium members across each of the Research Programs. We emphasize the importance of establishing ongoing and continuing collaboration with biostatisticians as a means of maximizing scientific collaborations that lead to impactful cancer research. The BSR aids members with projects that do not have dedicated funding for biostatistical support. In addition, the BSR assists members across all Programs in the development of grant proposals. It is expected that such proposals will have biostatistical support built into the budget, in which case ? if a grant is awarded ? a funded collaboration with a biostatistician would subsequently take place outside the auspices of the BSR. In this sense, the BSR frequently spawns NIH-funded research. The BSR is composed of six faculty- level statisticians and three masters-level statisticians, and the CCSG currently funds roughly 1.1 FTE. The level of support for each biostatistician of the BSR ranges from 5-20%, as each biostatistician is primarily funded by research grants and contracts independent of their BSR activities. The CCSG-supported effort ensures that a stable staff of highly skilled biostatisticians is available to Consortium investigators. The members of the BSR have many years of experience working collaboratively with clinical, population, and laboratory scientists and possess a wide range of expertise in statistical methods that are relevant to the Consortium, including clinical trial design (Phase I through Phase III), survival analysis (including competing risks), longitudinal data, diagnostics testing, biomarkers, prediction models, microbiome, genomic, proteomic, metabolomic, high-dimensional data analysis, multi-omic and data-integration methods, analysis of nonlinear time series including modeling and inference with ordinary differential equations, cancer survivorship, inverse- probability weighting, statistical genetics, biological pathway analysis, mixed model and kernel methods, quantile regression, and causal inference.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Fred Hutchinson Cancer Research Center
United States
Zip Code
Kuzma, Jessica N; Cromer, Gail; Hagman, Derek K et al. (2018) Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr :
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Puré, Ellen; Hingorani, Sunil R (2018) Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy. Trends Cancer 4:273-277
Yu, Hsiang; Cheng, Yu-Jen; Wang, Ching-Yun (2018) Methods for multivariate recurrent event data with measurement error and informative censoring. Biometrics 74:966-976
Linden, Hannah M; Peterson, Lanell M; Fowler, Amy M (2018) Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 13:415-422
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005
Winters, Brian R; Vakar-Lopez, Funda; Brown, Lisha et al. (2018) Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy. Urol Oncol 36:342.e7-342.e14
Molina, Yamile; Briant, Katherine J; Sanchez, Janeth I et al. (2018) Knowledge and social engagement change in intention to be screened for colorectal cancer. Ethn Health 23:461-479
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843

Showing the most recent 10 out of 1267 publications